CN109266617B - 一种人乳头瘤病毒16型全基因组感染性细胞模型 - Google Patents
一种人乳头瘤病毒16型全基因组感染性细胞模型 Download PDFInfo
- Publication number
- CN109266617B CN109266617B CN201811172192.9A CN201811172192A CN109266617B CN 109266617 B CN109266617 B CN 109266617B CN 201811172192 A CN201811172192 A CN 201811172192A CN 109266617 B CN109266617 B CN 109266617B
- Authority
- CN
- China
- Prior art keywords
- hpv16
- whole genome
- hpv
- dna
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000341655 Human papillomavirus type 16 Species 0.000 title claims abstract description 76
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 14
- 230000002458 infectious effect Effects 0.000 title claims abstract description 10
- 238000010367 cloning Methods 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 48
- 239000013612 plasmid Substances 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 230000003321 amplification Effects 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 238000012300 Sequence Analysis Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 229930193140 Neomycin Natural products 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 238000001976 enzyme digestion Methods 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 229960004927 neomycin Drugs 0.000 claims description 2
- 210000003370 receptor cell Anatomy 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 230000035755 proliferation Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 abstract description 10
- 238000004088 simulation Methods 0.000 abstract description 3
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 33
- 241000701806 Human papillomavirus Species 0.000 description 29
- 239000012634 fragment Substances 0.000 description 21
- 241000700605 Viruses Species 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000012124 Opti-MEM Substances 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 101150071673 E6 gene Proteins 0.000 description 3
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000008925 shengjing Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 101150013359 E7 gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000012595 freezing medium Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102220557633 DNA-directed RNA polymerase I subunit RPA12_Q14H_mutation Human genes 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000011316 allogeneic transplantation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 102200118211 rs33991294 Human genes 0.000 description 1
- 102220315424 rs759913674 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000004085 squamous epithelial cell Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811172192.9A CN109266617B (zh) | 2018-10-09 | 2018-10-09 | 一种人乳头瘤病毒16型全基因组感染性细胞模型 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811172192.9A CN109266617B (zh) | 2018-10-09 | 2018-10-09 | 一种人乳头瘤病毒16型全基因组感染性细胞模型 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109266617A CN109266617A (zh) | 2019-01-25 |
CN109266617B true CN109266617B (zh) | 2022-03-01 |
Family
ID=65196185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811172192.9A Active CN109266617B (zh) | 2018-10-09 | 2018-10-09 | 一种人乳头瘤病毒16型全基因组感染性细胞模型 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109266617B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110408677A (zh) * | 2019-07-27 | 2019-11-05 | 苏州丽纳芯生物科技有限公司 | 一种基于固态纳米孔结肠癌kras基因突变检测方法 |
CN111440772A (zh) * | 2020-03-26 | 2020-07-24 | 北京三元基因药业股份有限公司 | 抗人乳头瘤病毒药物筛选模型及其构建方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104928399A (zh) * | 2015-04-24 | 2015-09-23 | 深圳华大基因科技有限公司 | 引物组、试剂盒及其在hpv全基因组检测中的用途 |
WO2016015684A1 (zh) * | 2014-08-01 | 2016-02-04 | 广东拓谱康生物科技有限公司 | 携带人乳头瘤病毒16型突变型e7抗原基因的重组腺相关病毒载体及其构建方法与应用 |
CN105420196A (zh) * | 2015-12-23 | 2016-03-23 | 北京工业大学 | 一种稳定表达hpv16 e5蛋白细胞株的构建方法及应用 |
CN108929869A (zh) * | 2018-08-09 | 2018-12-04 | 亚能生物技术(深圳)有限公司 | Hpv全长基因组质控品的制备方法、扩增引物及检测试剂 |
-
2018
- 2018-10-09 CN CN201811172192.9A patent/CN109266617B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016015684A1 (zh) * | 2014-08-01 | 2016-02-04 | 广东拓谱康生物科技有限公司 | 携带人乳头瘤病毒16型突变型e7抗原基因的重组腺相关病毒载体及其构建方法与应用 |
CN104928399A (zh) * | 2015-04-24 | 2015-09-23 | 深圳华大基因科技有限公司 | 引物组、试剂盒及其在hpv全基因组检测中的用途 |
CN105420196A (zh) * | 2015-12-23 | 2016-03-23 | 北京工业大学 | 一种稳定表达hpv16 e5蛋白细胞株的构建方法及应用 |
CN108929869A (zh) * | 2018-08-09 | 2018-12-04 | 亚能生物技术(深圳)有限公司 | Hpv全长基因组质控品的制备方法、扩增引物及检测试剂 |
Non-Patent Citations (3)
Title |
---|
"HPV-16在HEK293T细胞中的复制以及HPV-16 L1病毒载体疫苗免疫效果的研究";吕涛;《中国优秀硕士学位论文全文数据库医药卫生科技辑》;20150816(第08期);第14页摘要和第16页1.1材料 * |
"人乳头瘤病毒16型全基因组克隆及其表达载体构建";孙云峰;《中国优秀硕士学位论文全文数据库医药卫生科技辑》;20141115(第11期);第14页2.2.1总DNA提取、第15页2.2.2 HPV16全基因克隆、第22-23页2.2.3构建环化的HPV16全基因组和第41页最后一段-第43页第一段 * |
吕涛."HPV-16在HEK293T细胞中的复制以及HPV-16 L1病毒载体疫苗免疫效果的研究".《中国优秀硕士学位论文全文数据库医药卫生科技辑》.2015,(第08期),第14页摘要和第16页1.1材料. * |
Also Published As
Publication number | Publication date |
---|---|
CN109266617A (zh) | 2019-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Halbert et al. | Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff | |
CN111471717B (zh) | 一种用于2019新冠病毒核酸检测的假病毒的制备方法 | |
Carroll et al. | A 29-nucleotide DNA segment containing an evolutionarily conserved motif is required in cis for cell-type-restricted repression of the chicken α-smooth muscle actin gene core promoter | |
CN112359022A (zh) | 检测用新型冠状病毒核酸假病毒标准物质及其制备方法 | |
CN109266617B (zh) | 一种人乳头瘤病毒16型全基因组感染性细胞模型 | |
CN112029803A (zh) | 一种慢病毒过表达病毒载体及其制备方法、用途 | |
CN110468155B (zh) | 一种用于拯救猪肠道甲型冠状病毒的系统、方法及应用 | |
CN101857633B (zh) | 一种水稻叶形控制基因srnl1及其应用 | |
CN111500633A (zh) | 基于基因编辑技术的重组金丝雀痘病毒构建方法 | |
CN101979598A (zh) | 一种携带荧光素酶报告基因的hsv-1 bac系统的构建方法 | |
Klimkait et al. | Adenovirus types 2 and 5 functions elicit replication and late expression of adenovirus type 12 DNA in hamster cells | |
CN105713866A (zh) | 人巨细胞病毒感染性克隆及其构建方法和应用 | |
CN105802997B (zh) | 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用 | |
CN114836437B (zh) | 牡丹PsMYB4基因在改变植物花瓣色斑颜色和大小方面的应用 | |
CN110904056B (zh) | 一种传染性支气管炎病毒rH120-YZS1Δ5a及其构建方法和应用 | |
CN110106171A (zh) | 长链非编码rna及其在调控植物耐低温中的应用 | |
CN113584080A (zh) | 一种Nluc标记的重组猪δ冠状病毒感染性克隆质粒的构建及其应用 | |
CN114395568A (zh) | 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用 | |
CN107034232B (zh) | Atg16l1基因在增强新城疫病毒的复制能力中的用途 | |
CN102747082B (zh) | 猪肌肉特异性itgb1bp2启动子及其应用 | |
CN116286982B (zh) | 一种hpv基因分型检测阳性参考品及其制备方法和应用 | |
CN110106172A (zh) | 一种长链非编码rna及其在调控植物耐低温中的应用 | |
US11913002B2 (en) | Modified plant endosperm specific promoter and use thereof | |
CN113564165B (zh) | 一种胞内编辑伪狂犬病毒关键基因的细胞株及其构建方法和应用 | |
CN111944849B (zh) | 应用hpv18间隔序列构建双顺反子表达质粒的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Sun Zhengrong Inventor after: Wu Yingying Inventor after: Lu Yiping Inventor after: Wu Si Inventor after: Wang Shuang Inventor after: Yu Miao Inventor after: Liu Miao Inventor after: Yao Xuechun Inventor after: Lu Xingzhong Inventor before: Wu Yingying Inventor before: Lu Yiping Inventor before: Wu Si Inventor before: Wang Shuang Inventor before: Yu Miao Inventor before: Liu Miao Inventor before: Yao Xuechun Inventor before: Lu Xingzhong |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240408 Address after: No. 42 Lianhe Road, Dadong District, Shenyang City, Liaoning Province, 110000, 702 Patentee after: Liaoning Lanyi Stem Cell Biotechnology Co.,Ltd. Country or region after: China Address before: 110003, 36, Miyoshi street, Heping District, Liaoning, Shenyang Patentee before: SHENGJING HOSPITAL OF CHINA MEDICAL University Country or region before: China |
|
TR01 | Transfer of patent right |